New group of potential diabetes drugs with fewer side effects can reprogram insulin-resistant cells to be healthier

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...

Sensor lights up to reveal scopolamine, a common substance used for sexual assault

A team from the Universitat Politècnica de València (UPV) has led the development of a new sensor capable of quickly and ...
Harvard Medical School

Researchers Now Understand How a New Class of Antivirals Works

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
The Economist

AI is transforming the pharma industry for the better

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...
American Council on Science and Health

The First New Motion-Sickness Drug in 40 Years: Hi-Ho, or Heave-Ho?

Does motion sickness turn you into a green, spewing mess? For plenty of people, the answer is yes. Current remedies may or ...

Engineered protein complex could help immunotherapies target hard-to-treat neuroblastoma

Researchers from Children's Hospital of Philadelphia (CHOP) have developed a method to help cancer immunotherapies reach ...

How major nuclear protein complexes control specialized gene regulation in cancer and beyond

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...
University of California

Rewriting the code: The inside story of the first CRISPR cure

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...